StockData

Arteris vs Everspin Technologies

AIP and MRAM side by side, both in electronic components and accessories. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How AIP and MRAM compare

Arteris is the larger company, worth 3.2 times as much as Everspin Technologies ($951M against $298M).

Arteris grew revenue faster over the last twelve months (41.0% versus 28.7% for Everspin Technologies).

Everspin Technologies keeps more of each dollar of sales as profit, with a net margin of −14.3% compared with −44.8% at Arteris.

Arteris scores higher on the StockData Score (8 against 7 for Everspin Technologies), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricAIPMRAM
Size and price
Market cap$951M$298M
Share price$19.34$12.25
Change, 1 year28.8%36.3%
Change, 5 years−19.8%0.41%
Beta (5Y)1.841.71
Employees29985
StockData Score
Total score8 (better)7
Valuation score00
Growth score3 (better)2
Performance score1 (better)0
Health score45 (better)
Dividend score00
Valuation
P/S10.2×4.3× (better)
P/B14.4×4.4× (better)
P/FCF438×–
FCF yield0.23% (better)−2.2%
Fair value$8.79$9.84
Margin of safety−120%−24.5% (better)
Growth
Revenue growth (TTM)41.0% (better)28.7%
Revenue growth, 5Y average17.3% (better)5.6%
Profitability
Gross margin86.9% (better)52.2%
Operating margin−46.2%−23.3% (better)
Net margin−44.8%−14.3% (better)
FCF margin2.3% (better)−9.3%
Return on equity−153%−14.8% (better)
Return on invested capital–−53.1%
Financial health
Debt / equity0.000.01 (better)
Interest coverage−207.7×–
Current ratio1.353.31 (better)
Altman Z-score2.236.49 (better)
Piotroski F-score6 (better)3
Dividends and buybacks
Dividend yield–0.00%
Years of dividend growth–0
Shareholder yield0.00%0.00%
Ownership
Held by institutions65.2%52.4%
Held by insiders40.0%7.3%
Insider net buying, 12 months−$122M−$19.8M (better)
Short interest, % of float8.1%14.5%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.